ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver"

  • 2017 American Transplant Congress

    Donor Lymphoid Chimerism in Early Recognition and Prediction of Clinical Outcome Caused by Acute Graft versus Host Disease After Solid Organ Transplant.

    A. Zhang,1 Y. Sun,2 K. Hashimoto,4 M. Fujiki,4 M. Askar,3 J. Fung,5 C. Miller,4 K. Abu-Elmagd,4 B. Eghtesad.4

    1Cleveland Clinic, Allogen Laboratories, Cleveland, OH; 2Avalon University School of Medicine, Willemstad, Netherlands Antilles; 3Baylor University Medical Center, Dallas, TX; 4Transplantation Center, Cleveland Clinic, Cleveland, OH; 5Transplantation Center, University of Chicago, Chicago, IL

    Introduction: Acute graft versus host disease (aGvHD) after solid organ transplant (SOT) is rare but related with high mortality. Early accurate diagnosis is critical for…
  • 2016 American Transplant Congress

    Utilization and Discard of HCV+ Donor Livers in the Advent of Direct-Acting Antiviral Therapy.

    M. Bowring, L. Kucirka, A. Massie, X. Luo, M. Sulkowski, D. Segev, C. Durand.

    JHU, Baltimore.

    While 45% of liver candidates are hepatitis C (HCV)-antibody positive (+) and might benefit from a HCV+ donor liver, only a small proportion receive one.…
  • 2016 American Transplant Congress

    Systematic Review and Meta-Analysis of the Impact of Computed Tomography Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation.

    J. van Vugt,1 S. Levolger,1 R. de Bruin,1 J. van Rosmalen,2 H. Metselaar,3 J. IJzermans.1

    1Surgery, Erasmus University Medical Center, Rotterdam, Netherlands; 2Biostatistics, Erasmus University Medical Center, Rotterdam, Netherlands; 3Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands.

    BackgroundAlthough liver transplant outcome has improved significantly, the shortage of human organs remains prevalent. Therefore, strict patient selection is of paramount importance. Recently, low CT-assessed…
  • 2016 American Transplant Congress

    Children Listed as Status 1B for Liver Transplantation Are Disenfranchised by MARS Therapy.

    A. Bakshi,1 M. Kueht,1 A. Rana,1,2 A. Akcan Arikan,3 J. Goss.1,2

    1Surgery, Division of Abdominal Transplantation and Hepatobiliry Surgery, Baylor College of Medicine, Houston, TX; 2Surgery, Division of Abdominal Transplantation, Texas Children's Hospital, Houston, TX; 3Pediatric Medicine, Intensive Care, Texas Children's Hospital, Houston, TX.

    Acute exacerbations of chronic liver failure in the pediatric population require advanced ICU care in order to survive to transplantation (OLT). Often, the patients are…
  • 2016 American Transplant Congress

    The mTORC2 Activation Is Critical for Hepato-Cytoprotection Against Ischemia and Reperfusion Injury.

    H. Zhou,1,2 J. Zhu,1,3 S. Yue,1 R. Busuttil,1 J. Kupiec-Weglinski,1 X. Wang,2 Y. Zhai.1

    1Surgery, David Geffen School of Medicine-University of California-Los Angeles, LA, CA; 2Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China; 3Liver Surgery, Renji Hospital, Shanghai, China.

    Background & AimsRapamycin and Everolimus have been used in liver transplant patients, particularly those with calcineurin inhibitor-related nephrotoxicity and hepatocellular carcinoma. Although designed as mTORC1…
  • 2016 American Transplant Congress

    The First 48 Months of an Australian Renal and Liver Organ Transplant Dermatology Database.

    L. Ge,1,2 P. Lowe.1,2

    1Department of Dermatology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; 2Faculty of Medicine, University of Sydney, Sydney, NSW, Australia.

    PurposeThere have been few studies of non-melanoma skin cancers in the Australian cohort, a population unique for its high ambient UV radiation and sun-long lifestyle.…
  • 2016 American Transplant Congress

    The Incidence, Risk Factors and Clinical Course of De Novo Hepatitis B Infection in Pediatric Living Donor Liver Transplantation.

    Z. Baris, F. Ozcay, G. Moray, M. Haberal.

    Pediatric Gastroenterology, Baskent University, Ankara, Turkey; Pediatric Gastroenterology, Baskent University, Ankara, Turkey; Department of General Surgery, Baskent University, Ankara, Turkey; Department of General Surgery, Baskent University, Ankara, Turkey.

    Aim: We evaluated the incidence, risk factors and clinical course of liver transplanted pediatric patients with de novo hepatitis B infection and the clinical course…
  • 2016 American Transplant Congress

    Clinical Significance of Solitary Pulmonary Nodules in Liver Transplant Recipients with Hepatocellular Carcinoma.

    O. Serrano,1 A. Bangdiwala,2 D. Vock,2 V. Kirchner,1 K. Yadav,1 A. Pugalendhi,1 E. Minja,1 T. Dunn,1 E. Finger,1 A. Matas,1 R. Kandaswamy,1 W. Payne,1 T. Pruett,1 S. Chinnakotla.1

    1Surgery, Univ. of Minnesota, Minneapolis, MN; 2Biostatistics and Bioinformatics Core, Masonic Cancer Center, Minneapolis, MN; 3Biostatistics, Univ. of Minnesota, Minneapolis, MN.

    PURPOSE: Currently, there are no guidelines for the management of solitary pulmonary nodules (SPN) in hepatocellular carcinoma (HCC) patients being evaluated for liver transplantation (LT).…
  • 2016 American Transplant Congress

    Fatty Liver in Non-Hepatic Organ Transplantation.

    N. Kemmer, A. Alsina.

    Tampa General Medical Group, Tampa, FL.

    With the availability of effective antiviral regimen for HCV, Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in western countries and…
  • 2016 American Transplant Congress

    Limited Hepatitis B Immune Globulin Following Liver Transplant for Hepatitis B.

    T. Sievers, J. Thompson, J. Lake.

    Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN.

    IntroductionThe hypothesis of this study was that the long-term outcomes in liver transplant (LTx) patients with hepatitis B virus (HBV) who were treated with nucleos(t)ide…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 50
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences